➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Moodys
Medtronic
McKesson
McKinsey

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Indivior Inc. v. Mylan Technologies Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-11-04 1 Complaint United States Patent Nos. 8,475,832 (“the ʼ832 patent”), 8,017,150 (“the ʼ150 patent”), and 8,603,514…ʼ150 patent, and Plaintiff Indivior is an exclusive licensee of the ʼ150 patent. The ʼ150 patent, entitled…ʼ514 patent, and Plaintiff Indivior is an exclusive licensee of the ʼ514 patent. The ʼ514 patent, entitled…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…8,603,514 (“the ’514 patent”) (collectively, “the patents-in-suit”). Case 1:15-cv-01016-RGA Document 1 Filed External link to document
2017-05-30 147 Notice of Service Regarding Alvogen's Infringement of U.S. Patent Number 8,017,150; and 5. Expert Report of Dr. Robert K. …'homme Regarding Alvogen's Infringement of U.S. Patent Number 8,603,514; 3. Expert Report of Martyn C.… Ph.D. Regarding Alvogen's Infringement of U.S. Patent No. 8,603,514; 4. Expert Report of Dr. Robert K…'homme Regarding Alvogen's Infringement of U.S. Patent Number 8,900,497. filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware External link to document
2017-05-30 149 Notice of Service . Regarding Mylan's Infringement of U.S. Patent No. 8,603,514; 3. Expert Report of Dr. Robert K. Prud'…Regarding Mylan's Infringement of U.S. Patent Number 8,603,514; and 4. Expert Report of Dr. Robert K. …Prud'homme Regarding Mylan's Infringement of U.S. Patent Number 8,900,497 filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware External link to document
2017-06-29 155 Notice of Service Fassihi, Ph.D. Regarding Infringement of U.S. Patent Nos. 8,017,150 and 8,900,497 HIGHLY CONFIDENTIAL - OUTSIDE…Marcio S. Carvalho Regarding Infringement of U.S. Patent Nos. 8,603,514 and 8,900,497; and 2) Rebuttal Expert…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware External link to document
2017-06-29 156 Notice of Service Prud'homme Regarding Validity of U.S. Patent Numbers 8,603,514 & 8,900,497 filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware External link to document
2017-06-29 157 Notice of Service Langer, Sc.D. regarding validity of U.S. Patent Nos. 8,603,514 and 8,900,497 filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware External link to document
2017-07-25 167 Notice of Service Alvogen's Infringement of U.S. Patent Numbers 8,603,514, 8,900,497 and 8,017,150 filed by Indivior Inc., Indivior… Ph.D. regarding Alvogen's Infringement of U.S. Patent No. 8,603,514; (2) Reply Expert Report of Dr. James…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Colorcon
Baxter
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.